ARTICLE | Distillery Therapeutics
Therapeutics: CD38
September 17, 2015 7:00 AM UTC
Studies in rats and mice suggest NADPH therapy and CD38 inhibition could help treat and prevent, respectively, reductions in coronary blood flow after ischemia/reperfusion injury. In rats, cardiac lev...